Features Archives - Page 7 of 15

Features

Targeted protein degraders are redefining how small molecules look and act

The new modality promises to open up the human proteome to drug developers, but first they will need to work out the rules When the…

clement19.02.2018

Features

Roche accelerates development of cancer treatments

The Basel-based pharma company Roche is to acquire the U.S. company Flatiron Health, which develops software solutions for use in oncology.

clement16.02.2018

Features

Santhera licenses Polyphor cystic fibrosis drug

The pharma company Santhera Pharmaceuticals has obtained the worldwide exclusive license for the product candidate POL6014. Developed by Polyphor, the drug has the potential to…

clement15.02.2018

Features

“I enjoy thinking about seemingly unsolvable problems”

Andreas Plückthun continues his research where others stop: 40 employees work in his laboratory on protein engineering. Their results form the basis for three biotech…

clement09.02.2018

Features

BaseLaunch up to a solid Phase II start

BaseLaunch has officially started Phase II of its accelerator program, and four startups are receiving grants ranging from 120,000 to 250,000 Swiss francs. This non-dilutive…

clement30.01.2018

Features

Novartis steps in to grab ex-US rights to pioneering gene therapy Luxturna with $170M deal

clement26.01.2018

Features

Roivant Sciences to join BaseLaunch Accelerator as Healthcare Partner

Roivant becomes the fifth healthcare partner of BaselArea.swiss accelerator program joining Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer and Roche. BaseLaunch today announced that…

clement18.01.2018

Features

Features

Targeted protein degraders are redefining how small molecules look and act

Roche accelerates development of cancer treatments

Santhera licenses Polyphor cystic fibrosis drug

“I enjoy thinking about seemingly unsolvable problems”

BaseLaunch up to a solid Phase II start

Novartis steps in to grab ex-US rights to pioneering gene therapy Luxturna with $170M deal

Roivant Sciences to join BaseLaunch Accelerator as Healthcare Partner

YC Bio – new way for funding early-stage life science companies

Billionaire-backed Juvenescence primes the anti-aging pipeline pump with a $12M seed round

Roche pens neurological, developmental disorder drug discovery pact with Confo

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us